Adjunct extended-release valproate semisodium in late life schizophrenia
dc.contributor.author | Sajatovic, Martha | en_US |
dc.contributor.author | Coconcea, Nicoleta | en_US |
dc.contributor.author | Ignacio, Rosalinda V. | en_US |
dc.contributor.author | Blow, Frederic C. | en_US |
dc.contributor.author | Hays, Robert W. | en_US |
dc.contributor.author | Cassidy, Kristin A. | en_US |
dc.contributor.author | Meyer, William J. | en_US |
dc.date.accessioned | 2008-03-06T19:10:38Z | |
dc.date.available | 2009-02-03T16:28:50Z | en_US |
dc.date.issued | 2008-02 | en_US |
dc.identifier.citation | Sajatovic, Martha; Coconcea, Nicoleta; Ignacio, Rosalinda V.; Blow, Frederic C.; Hays, Robert W.; Cassidy, Kristin A.; Meyer, William J. (2008). "Adjunct extended-release valproate semisodium in late life schizophrenia." International Journal of Geriatric Psychiatry 23(2): 142-147. <http://hdl.handle.net/2027.42/58029> | en_US |
dc.identifier.issn | 0885-6230 | en_US |
dc.identifier.issn | 1099-1166 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/58029 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17582828&dopt=citation | en_US |
dc.description.abstract | Objective Adjunctive anticonvulsant medications may benefit some individuals with schizophrenia, however data on adjunct anticonvulsants in older adults with schizophrenia is limited. This prospective, 12-week open label study evaluated adjunct extended-release valproate semisodium (divalproex) in 20 older adults with schizophrenia. Methods The study was conducted at an academic psychiatry clinic in the mid-western United States. Participants were self-referred from posted advertisements or referred by clinic practitioners. Extended-release valproate semisodium was added onto antipsychotic treatment. Individuals with active substance use disorders or active significant medical comorbidity were excluded. Primary outcome measures included the Positive and Negative Syndrome Scale (PANSS), Geriatric Depression Scale (GDS) and Global Assessment Scale (GAS). Tolerability was evaluated via patient self-reported side effects, change from baseline in body weight and change on abnormal movement scales. Results Patients (mean age 61 years, range 49.8–79.2 years) had significant reductions in psychosis scores as measured by the Positive and Negative Syndrome Scale (PANSS) p < 0.01, as well as in global functioning as measured by the Global Assessment Scale (GAS) p < 0.01 and depression as measured by the Geriatric Depression Scale (GDS) p < 0.05. Mean dose of extended-release valproate semisodium was 587.50 mg/day SD ± 247.02. Extended-release valproate semisodium was well tolerated in this older adult population. The primary adverse effect was sedation, which appeared to be relatively dose and titration-speed dependent. Weight change was not significant. Conclusion While extended-release valproate semisodium appears efficacious and well tolerated in older adults with schizophrenia, data from larger, controlled trials is needed. Copyright © 2007 John Wiley & Sons, Ltd. | en_US |
dc.format.extent | 79448 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | John Wiley & Sons, Ltd. | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Neuroscience, Neurology and Psychiatry | en_US |
dc.title | Adjunct extended-release valproate semisodium in late life schizophrenia | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Gay/Lesbian/Bisexual/Transgender Studies | en_US |
dc.subject.hlbsecondlevel | Geriatrics | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbsecondlevel | Judaic Studies | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Social Work | en_US |
dc.subject.hlbsecondlevel | Women's and Gender Studies | en_US |
dc.subject.hlbtoplevel | Humanities | en_US |
dc.subject.hlbtoplevel | Social Sciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Serious Mental Illness Treatment Research and Evaluation Center (SMITREC), Health Services Research and Development, Ann Arbor VA Healthcare System, USA ; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Serious Mental Illness Treatment Research and Evaluation Center (SMITREC), Health Services Research and Development, Ann Arbor VA Healthcare System, USA ; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio, USA ; Department of Psychiatry, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA. | en_US |
dc.contributor.affiliationother | Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio, USA ; NorthEast Ohio Health Services, Cleveland, Ohio, USA | en_US |
dc.contributor.affiliationother | NorthEast Ohio Health Services, Cleveland, Ohio, USA | en_US |
dc.contributor.affiliationother | Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio, USA | en_US |
dc.contributor.affiliationother | Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio, USA | en_US |
dc.identifier.pmid | 17582828 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/58029/1/1854_ftp.pdf | |
dc.identifier.doi | http://dx.doi.org/10.1002/gps.1854 | en_US |
dc.identifier.source | International Journal of Geriatric Psychiatry | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.